Nestle stock rises on a 393 million USD Brazil push
Published on 09/03/2026 at 16:06 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Nestle stock (CH0038863350) was down 0.8 percent to CHF 78.00 on the SIX at 9:28 AM on September 3, 2026, while Reuters reported a new 2 billion reais investment in Brazil. The plan includes 600 million reais for an infant formula plant in Minas Gerais and gives the share a fresh corporate catalyst.
Brazil adds a new growth line
According to the Reuters report, the 2 billion reais commitment runs through 2028 and the new factory in Ituiutaba is scheduled to start construction in 2027. Reuters also said the site should begin operations from 2028 and initially make Nestogeno, Nestonutri, Ninho 1+ and Ninho 3+ infant formulas.
The allocation for nutrition and health equals about 30 percent of the 7 billion reais Nestle has earmarked for Brazil between 2025 and 2028. That split matters because it shows where management sees the next layer of growth spending.
Price and range
The market backdrop is still measurable in concrete terms: the stock touched CHF 77.97 intraday, opened at CHF 78.39 and traded 11.65 percent below its 52-week high of CHF 87.09 reached on July 22, 2026. Volume stood at 74,049 shares, which is enough to show active trading but not enough to change the broader picture on its own.
For comparison, the 52-week low is CHF 70.29 from January 26, 2026. Against that floor, the current quote was still 10.9 percent higher, which leaves the share in the middle of its yearly range.
Nestle Brazil capex and infant formula output
The Brazil project is the clearest current company-specific driver and ties investment to a named product line, a factory site and a 2028 start-up window.
Investor angle
For investors, the key point is that the Brazil plan is large enough to matter but still staged over several years, so the immediate share reaction depends more on execution than on the headline figure alone. The 2028 start date also pushes the revenue question into later reporting periods.
Plant and products
The new facility in Minas Gerais is meant to produce infant formula first, not a broad new consumer portfolio. Reuters said the initial lineup will include Nestogeno, Nestonutri, Ninho 1+ and Ninho 3+, which keeps the project tightly linked to Nestle's nutrition and health division.
Stock level
Nestle stock ended the morning at CHF 78.00 on September 3, 2026, with the session low at CHF 77.97 and the 52-week high at CHF 87.09. That leaves the share CHF 9.09 below its peak and still well above the CHF 70.29 low from January 26, 2026.
Nestle stock at a glance
- Company: Nestle S.A.
- ISIN: CH0038863350
- Ticker: NESN
- Trading venue: SIX Swiss Exchange
- Price (as of September 3, 2026, 9:28 AM): CHF 78.00
- Market capitalization: CHF 218.0 billion (as of September 3, 2026)
- Sector / Industry: Consumer Staples / Food Products
- Index membership: SMI
- Next earnings date: February 18, 2027
